No­vo Nordisk, GSK pause some Twit­ter ad spend­ing af­ter Musk takeover

Eli Lil­ly isn’t the on­ly phar­ma com­pa­ny that’s paused ad­ver­tis­ing on Twit­ter in re­cent days.

No­vo Nordisk, one of the three ma­jor in­sulin drug­mak­ers along …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER